2018
DOI: 10.1177/2374289518766521
|View full text |Cite
|
Sign up to set email alerts
|

A Next-Generation Sequencing Primer—How Does It Work and What Can It Do?

Abstract: Next-generation sequencing refers to a high-throughput technology that determines the nucleic acid sequences and identifies variants in a sample. The technology has been introduced into clinical laboratory testing and produces test results for precision medicine. Since next-generation sequencing is relatively new, graduate students, medical students, pathology residents, and other physicians may benefit from a primer to provide a foundation about basic next-generation sequencing methods and applications, as we… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
40
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 72 publications
(45 citation statements)
references
References 140 publications
(158 reference statements)
1
40
0
Order By: Relevance
“…Molecular genetics testing was performed using a Massively Parallel Sequencing assay developed for clinical genetics testing of PCD at the UNC hospitals Molecular Genetics Laboratory (Figure ). The test consists of screening the complete coding region and splice‐site junctions for the 35 genes associated with PCD as well as two genes ( CFTR and RAG1 ) that have overlapping phenotypes.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Molecular genetics testing was performed using a Massively Parallel Sequencing assay developed for clinical genetics testing of PCD at the UNC hospitals Molecular Genetics Laboratory (Figure ). The test consists of screening the complete coding region and splice‐site junctions for the 35 genes associated with PCD as well as two genes ( CFTR and RAG1 ) that have overlapping phenotypes.…”
Section: Methodsmentioning
confidence: 99%
“…Parallel Sequencing 15,16 assay developed for clinical genetics testing of PCD at the UNC hospitals Molecular Genetics Laboratory 17 (Figure 1).…”
Section: Molecular Genetics Testing Was Performed Using a Massivelymentioning
confidence: 99%
“…Although the limited approach of Sanger sequencing is costly and inefficient for large-scale genomic sequencing, it remains the most widely accepted means to validate variants identified by NGS methodologies, particularly for clinically reportable findings. 86 Targeted gene panels typically focus on sequencing genes that are known to be causative of or associated with a given phenotype. While they can be convenient and are commonly used, the gene lists are often too restrictive, can rapidly become out of date, and can miss unanticipated findings.…”
Section: Comparison Of Sequencing Approachesmentioning
confidence: 99%
“…Sixth, data analysis. Data analysis includes the quality evaluation of the sequence, alignment to reference sequence to identify some possible variations such as single nucleotide polymorphism (SNP) or insertiondeletion (indel) identification, phylogenetic or metagenomic analysis, as well as the identification, interpretation, and classification of pathogenic variants [122,123].…”
Section: Next-generation Sequencingmentioning
confidence: 99%